TY - JOUR
T1 - An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD
AU - Poe, Jonathan C.
AU - Jia, Wei
AU - Su, Hsuan
AU - Anand, Sarah
AU - Rose, Jeremy J.
AU - Tata, Prasanthi V.
AU - Suthers, Amy N.
AU - Jones, Corbin D.
AU - Kuan, Pei Fen
AU - Vincent, Benjamin G.
AU - Serody, Jonathan S.
AU - Horwitz, Mitchell E.
AU - Ho, Vincent T.
AU - Pavletic, Steven Z.
AU - Hakim, Frances T.
AU - Owzar, Kouros
AU - Zhang, Dadong
AU - Blazar, Bruce R.
AU - Siebel, Christian W.
AU - Chao, Nelson J.
AU - Maillard, Ivan
AU - Sarantopoulos, Stefanie
N1 - Publisher Copyright:
© 2017, American Society of Hematology. All rights reserved.
PY - 2017/11/9
Y1 - 2017/11/9
N2 - B-cell receptor (BCR)-activated B cells contribute to pathogenesis in chronic graft-versus-host disease (cGVHD), a condition manifested by both B-cell autoreactivity and immune deficiency. We hypothesized that constitutive BCR activation precluded functional B-cell maturation in cGVHD. To address this, we examined BCR-NOTCH2 synergy because NOTCH has been shown to increase BCR responsiveness in normal mouse B cells. We conducted ex vivo activation and signaling assays of 30 primary samples from hematopoietic stem cell transplantation patients with and without cGVHD. Consistent with a molecular link between pathways, we found that BCR-NOTCH activation significantly increased the proximal BCR adapter protein BLNK. BCR-NOTCH activation also enabled persistent NOTCH2 surface expression, suggesting a positive feedback loop. Specific NOTCH2 blockade eliminated NOTCH-BCR activation and significantly altered NOTCH downstream targets and B-cell maturation/effector molecules. Examination of the molecular underpinnings of this “NOTCH2-BCR axis” in cGVHD revealed imbalanced expression of the transcription factors IRF4 and IRF8, each critical to B-cell differentiation and fate. All-trans retinoic acid (ATRA) increased IRF4 expression, restored the IRF4-to-IRF8 ratio, abrogated BCR-NOTCH hyperactivation, and reduced NOTCH2 expression in cGVHD B cells without compromising viability. ATRA-treated cGVHD B cells had elevated TLR9 and PAX5, but not BLIMP1 (a gene-expression pattern associated with mature follicular B cells) and also attained increased cytosine guanine dinucleotide responsiveness. Together, we reveal a mechanistic link between NOTCH2 activation and robust BCR responses to otherwise suboptimal amounts of surrogate antigen. Our findings suggest that peripheral B cells in cGVHD patients can be pharmacologically directed from hyperactivation toward maturity.
AB - B-cell receptor (BCR)-activated B cells contribute to pathogenesis in chronic graft-versus-host disease (cGVHD), a condition manifested by both B-cell autoreactivity and immune deficiency. We hypothesized that constitutive BCR activation precluded functional B-cell maturation in cGVHD. To address this, we examined BCR-NOTCH2 synergy because NOTCH has been shown to increase BCR responsiveness in normal mouse B cells. We conducted ex vivo activation and signaling assays of 30 primary samples from hematopoietic stem cell transplantation patients with and without cGVHD. Consistent with a molecular link between pathways, we found that BCR-NOTCH activation significantly increased the proximal BCR adapter protein BLNK. BCR-NOTCH activation also enabled persistent NOTCH2 surface expression, suggesting a positive feedback loop. Specific NOTCH2 blockade eliminated NOTCH-BCR activation and significantly altered NOTCH downstream targets and B-cell maturation/effector molecules. Examination of the molecular underpinnings of this “NOTCH2-BCR axis” in cGVHD revealed imbalanced expression of the transcription factors IRF4 and IRF8, each critical to B-cell differentiation and fate. All-trans retinoic acid (ATRA) increased IRF4 expression, restored the IRF4-to-IRF8 ratio, abrogated BCR-NOTCH hyperactivation, and reduced NOTCH2 expression in cGVHD B cells without compromising viability. ATRA-treated cGVHD B cells had elevated TLR9 and PAX5, but not BLIMP1 (a gene-expression pattern associated with mature follicular B cells) and also attained increased cytosine guanine dinucleotide responsiveness. Together, we reveal a mechanistic link between NOTCH2 activation and robust BCR responses to otherwise suboptimal amounts of surrogate antigen. Our findings suggest that peripheral B cells in cGVHD patients can be pharmacologically directed from hyperactivation toward maturity.
UR - http://www.scopus.com/inward/record.url?scp=85033445486&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85033445486&partnerID=8YFLogxK
U2 - 10.1182/blood-2017-05-782466
DO - 10.1182/blood-2017-05-782466
M3 - Article
C2 - 28851699
AN - SCOPUS:85033445486
SN - 0006-4971
VL - 130
SP - 2131
EP - 2145
JO - Blood
JF - Blood
IS - 19
ER -